Rocket


Overview
Financials
News + Filings
Key Docs
Insiders

 
 

CLARUS THERAPEUTICS INC (CRXT) Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-09Dec-31-08Dec-31-07
Revenues2.81.81.0
            Revenue growth50.5%78.7% 
Cost of goods sold1.51.10.8
Gross profit1.30.80.3
            Gross margin46.1%42.0%26.6%
General and administrative1.51.10.8
EBIT-4.2-2.9-1.8
            EBIT margin-153.9%-158.0%-173.4%
Pre-tax income-4.2-2.9-1.8
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income0.00.00.0
            Net margin-0.2%-0.2%-0.2%
 
Diluted EPS($15.13)($10.47)($6.60)
Shares outstanding (diluted)0.00.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy